AVANIR Pharmaceuticals To Present Zenvia Phase III Data At American Academy Of Neurology Annual Meeting
Links shared publicly online about this topic.
- 1,255total visits
AVANIR Pharmaceuticals To Present Zenvia Phase III Data At American Academy Of Neurology Annual Meeting
View full resource at medicalnewstoday.com
Most Recently Shared on April 8, 2010 at 7:09 pm By:
AVANIR Pharmaceuticals To Present Zenvia Phase III Data At American Academy Of Neurology Annual Meeting http://mnt.to/3zYC #clinicaltrials
Also Shared By:
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the” View full resource at medicalnewstoday.com
Most Recently Shared on April 18, 2010 at 12:05 pm By:
MNT Neurology News Neurology and Health News
AVANIR Pharmaceuticals Presents Zenvia Phase III Safety Data At The American Academy Of Neurology Annual Meeting http://mnt.to/3BnQ
AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting
news-medical.net — “AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia" (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.” View full resource at news-medical.net
Most Recently Shared on April 15, 2010 at 12:26 pm By:
Stroke News: AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting: AVANI... http://twurl.nl/rbynjt
Three scientific posters featuring Zenvia to be presented at AAN Annual Meeting
news-medical.net — “AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia" (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.” View full resource at news-medical.net
Most Recently Shared on April 6, 2010 at 1:10 pm By:
Stroke News: Three scientific posters featuring Zenvia to be presented at AAN Annual Meeting: AVANIR Pharmaceuti... http://twurl.nl/148h7j
AVANIR To Present Pivotal Zenvia Phase III Data At American Neurological Association And World Congress On Controversies In Neurology Annual Meetings
medicalnewstoday.com — “AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced it will present detailed data from the Phase III confirmatory STAR trial in the treatment of pseudobulbar affect (PBA) at the 3rd World ” View full resource at medicalnewstoday.com
Most Recently Shared on October 8, 2009 at 12:41 pm By:
MNT Neurology News Neurology and Health News
AVANIR To Present Pivotal Zenvia Phase III Data At American Neurological Association And World Congress On Cont.. http://bit.ly/2XeMu
Advertisement
MNT Neurology News
@mnt_neurology
AVANIR To Present Pivotal Zenvia Phase III Data At American Neurological Association And World Congress On Cont.. http://bit.ly/2XeMu
1 year ago...